March 2016 Issue Table Of Contents

From The Editor

• The U.S. Tax Man Cometh, The U.S. Corporations Leaveth

Feature Articles

• The Building Of Ironwood Pharmaceuticals
• Abbey Meyers: Did The Pioneer Of Orphan Drugs Spark Biopharma?
• Hot New Therapeutic MOAs versus Neurodegenerative Diseases

Capitol Perspectives

• Negotiation of Medicare Drug Prices

Companies To Watch

• Egalet

Inside The Industry

• 3-D Printed Medications Face Hurdles, But Growth Continues
• Insights For Creating A Combo Products Centre of Excellence
• How Crowdfunding Can Expand Funding Opportunities For Biotechs

Industry Leader

• Life Sciences Companies Have Reason For Optimism In 2016

Leadership Lessons

• How Social Media Will Upgrade Your Leadership

Ask The Board

• Will CRISPR Deliver On The Promise To Transform The Field Of Biology?
• What Are Some Of Your Favorite Leadership Books?
• How Does Single-Use Technology (SUT) Impact Sustainability Goals In The Industry?